Evidence map›Paper›PMID 35479328›Full record

ArticleFrontiers in pharmacology2022

Integrated Metabolomics and Network Pharmacology Analysis Immunomodulatory Mechanisms of Qifenggubiao Granules.

Bindan Guo, Wenting Dong, Jinhai Huo, Guodong Sun, Zhiwei Qin, Xiaodong Liu, Bihai Zhang, Weiming Wang

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution.

Bindan GuoInstitute of Chinese Materia Medica, Heilongjiang Academy of Chinese Medicine Sciences, Harbin, China.
Wenting DongInstitute of Chinese Materia Medica, Heilongjiang Academy of Chinese Medicine Sciences, Harbin, China.
Jinhai HuoInstitute of Chinese Materia Medica, Heilongjiang Academy of Chinese Medicine Sciences, Harbin, China.
Guodong SunInstitute of Chinese Materia Medica, Heilongjiang Academy of Chinese Medicine Sciences, Harbin, China.
Zhiwei QinInstitute of Chinese Materia Medica, Heilongjiang Academy of Chinese Medicine Sciences, Harbin, China.
Xiaodong LiuInstitute of Chinese Materia Medica, Heilongjiang Academy of Chinese Medicine Sciences, Harbin, China.
Bihai ZhangInstitute of Chinese Materia Medica, Heilongjiang Academy of Chinese Medicine Sciences, Harbin, China.
Weiming WangInstitute of Chinese Materia Medica, Heilongjiang Academy of Chinese Medicine Sciences, Harbin, China.
Institute of Chinese Materia Medica

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

cyclophosphamideimmunosuppressionmetabonomicsnetwork pharmacologyQifenggubiao granules

Identifiers

PMID35479328
PMCPMC9037242
OpenAlexW4223639674

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.